Form 8-K CATALYST PHARMACEUTICALS For: Jan 24
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Börse:
14,502€
1,59%
Echtzeit-Aktienkurs Catalyst Pharmaceuticals Inc.
Bid:
14,456€
Ask:
14,548€
Nachrichten zur Catalyst Pharmaceuticals Inc. Aktie
Zacks.com featured highlights include Lamb Weston, Pinduoduo and Catalyst Pharmaceuticals
Lamb Weston, Pinduoduo and Catalyst Pharmaceuticals are part of the Zacks Screen of the Week article....…
3 Top-Rated Profitable Stocks to Buy Using Net Income Ratio
Lamb Weston (LW), Pinduoduo (PDD), and Catalyst Pharmaceuticals (CPRX) have been selected as the top picks with a high net…
Catalyst Pharmaceuticals Completes the Acquisition of U.S. Rights to FYCOMPA® (Perampanel) CIII
Strengthens its Commercial Portfolio with the First and Only AMPA Receptor Antagonist Marketed Product for Epilepsy...…
Form 8-K CATALYST PHARMACEUTICALS For: Jan 23
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Is Trending Stock Catalyst Pharmaceuticals, Inc. (CPRX) a Buy Now?
Zacks.com users have recently been watching Catalyst (CPRX) quite a bit. Thus, it is worth knowing the facts that could…
Catalyst Pharma Down 34% as Teva Eyes Generic Version of Firdapse
Catalyst Pharma Down 34% as Teva Eyes Generic Version of Firdapse...…
Why Catalyst Pharmaceuticals Shares Are Moving
Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) shares are trading lower by 13.46% to $18.00 Monday morning after Teva Pharmaceuticals stated it…
Form 8-K CATALYST PHARMACEUTICALS For: Jan 18
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Catalyst Pharmaceuticals Notified of Abbreviated New Drug Application Filing for FIRDAPSE®
CORAL GABLES, Fla., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (NASDAQ: CPRX), a commercial-stage biopharmaceutical…
Catalyst Pharmaceutical (CPRX) Dips More Than Broader Markets: What You Should Know
Catalyst Pharmaceutical (CPRX) closed the most recent trading day at $20.27, moving -0.78% from the previous trading session....…
Zacks Investment Ideas feature highlights: XBI, Catalyst Pharma, Prometheus Biosciences, Sage Therapeutics and IBB
XBI, Catalyst Pharma, Prometheus Biosciences, Sage Therapeutics and IBB are part of the Zacks Investment Ideas article....…
Form 8-K CATALYST PHARMACEUTICALS For: Dec 17
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Catalyst Pharmaceuticals Shares Rise 12%, Hit All-Time High
Catalyst Pharmaceuticals Shares Rise 12%, Hit All-Time High...…
Catalyst Pharma gains U.S. rights to Eisai epilepsy drug Fycompa
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Catalyst Pharmaceuticals to Acquire U.S. Commercial Rights to FYCOMPA® (Perampanel) CIII From Eisai Co., Ltd
Acquisition Expands The Companys Commercial Portfolio With An Established U.S. Marketed Product...…
Insiderhandel: Chief Medical Officer verkauft Aktien von Catalyst Pharmaceuticals im Wert von 99.718$
Ingenito, Gary - Vorstand - Tag der Transaktion: 2022-12-06...…
Insiderhandel: President and CEO verkauft Aktien von Catalyst Pharmaceuticals im Wert von 5.467.700$
Mcenany, Patrick J. - Vorstand - Tag der Transaktion: 2022-11-18...…
Insiderhandel: President and CEO verkauft Aktien von Catalyst Pharmaceuticals im Wert von 2.299.800$
Mcenany, Patrick J. - Vorstand - Tag der Transaktion: 2022-11-21...…
Catalyst Pharma hits 52-week high amid acquisition hopes
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Catalyst Pharmaceutical (CPRX) Tops Q3 Earnings and Revenue Estimates
Catalyst (CPRX) delivered earnings and revenue surprises of 5.26% and 6.40%, respectively, for the quarter ended September 2022. Do the…
Catalyst Pharmaceuticals to Report Third Quarter 2022 Financial Results on November 9, 2022
Conference Call and Webcast to be held on November 10, 2022, at 8:30 AM ET Conference Call and Webcast to…
Zacks Industry Outlook Highlights Jazz Pharmaceuticals, Catalyst Pharmaceuticals, Aerie Pharmaceuticals, Larimar Therapeutics and Fusion Therapeutics
Jazz Pharmaceuticals, Catalyst Pharmaceuticals, Aerie Pharmaceuticals, Larimar Therapeutics and Fusion Therapeutics have been highlighted in this Industry Outlook article....…
Is Catalyst Pharmaceuticals (CPRX) Stock Outpacing Its Medical Peers This Year?
Here is how Catalyst Pharmaceutical (CPRX) and IMARA Inc. (IMRA) have performed compared to their sector so far this year....…
Form 8-K CATALYST PHARMACEUTICALS For: Sep 29
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Catalyst Pharmaceuticals Gets FDA OK for Firdapse in Children >CPRX
Catalyst Pharmaceuticals Gets FDA OK for Firdapse in Children >CPRX...…
Catalyst Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application for FIRDAPSE® Expanding Patient Population to Include Pediatric Patients
FIRDAPSE is Now a Treatment Option for All LEMS Patients 6 Years of Age and Older in the U.S. FIRDAPSE…
Insiderhandel: VP, Treasurer and CFO verkauft Aktien von Catalyst Pharmaceuticals im Wert von 713.940$
Grande, Alicia - Vorstand - Tag der Transaktion: 2022-09-23...…
Insiderhandel: VP, Treasurer and CFO verkauft Aktien von Catalyst Pharmaceuticals im Wert von 1.214.640$
Grande, Alicia - Vorstand - Tag der Transaktion: 2022-09-16...…
Form 8-K CATALYST PHARMACEUTICALS For: Sep 19
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: Chief Strategy Officer verkauft Aktien von Catalyst Pharmaceuticals im Wert von 263.921$
Sundaram, Preethi - Vorstand - Tag der Transaktion: 2022-09-15...…
Insiderhandel: VP, Treasurer and CFO verkauft Aktien von Catalyst Pharmaceuticals im Wert von 778.650$
Grande, Alicia - Vorstand - Tag der Transaktion: 2022-09-14...…
Insiderhandel: Chief Medical & Reg. Officer verkauft Aktien von Catalyst Pharmaceuticals im Wert von 2.241.459$
Ingenito, Gary - Vorstand - Tag der Transaktion: 2022-09-14...…
Catalyst Pharma falls after a series of insider sales
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: President and CEO verkauft Aktien von Catalyst Pharmaceuticals im Wert von 1.238.047$
Mcenany, Patrick J. - Vorstand - Tag der Transaktion: 2022-09-13...…
Insiderhandel: Aufsichtsrat verkauft Aktien von Catalyst Pharmaceuticals im Wert von 315.000$
Coelho, Philip H. - Aufsichtsrat - Tag der Transaktion: 2022-09-14...…
Insiderhandel: Chief Operating Officer verkauft Aktien von Catalyst Pharmaceuticals im Wert von 1.824.367$
Miller, Steve - Vorstand - Tag der Transaktion: 2022-09-13...…
Insiderhandel: President and CEO verkauft Aktien von Catalyst Pharmaceuticals im Wert von 14.594.684$
Mcenany, Patrick J. - Vorstand - Tag der Transaktion: 2022-09-14...…
Insiderhandel: Aufsichtsrat verkauft Aktien von Catalyst Pharmaceuticals im Wert von 306.800$
Denkhaus, Donald A. - Aufsichtsrat - Tag der Transaktion: 2022-09-14...…
Insiderhandel: Aufsichtsrat verkauft Aktien von Catalyst Pharmaceuticals im Wert von 157.000$
Coelho, Philip H. - Aufsichtsrat - Tag der Transaktion: 2022-09-13...…
Is Catalyst Pharmaceuticals (CPRX) Outperforming Other Medical Stocks This Year?
Here is how Catalyst Pharmaceutical (CPRX) and Lyell Immunopharma (LYEL) have performed compared to their sector so far this year....…
Why Catalyst Pharmaceuticals Shares Are Popping Off
Catalyst Pharmaceuticals Inc. (NASDAQ: CPRX) shares are trading higher by 6.40% to $16.12 Tuesday after it was announced the company will…
Catalyst Pharma Shares Rise 10%, Co. Will Join S&P SmallCap 600
Catalyst Pharma Shares Rise 10%, Co. Will Join S&P SmallCap 600...…
Catalyst Pharmaceuticals Set to Join S&P SmallCap 600
NEW YORK, Sept. 12, 2022 /PRNewswire/ -- Catalyst Pharmaceuticals Inc. (NASD: CPRX) will replace Mantech International Corp. (NASD: MANT) in…
Catalyst Pharmaceuticals gains 9% on SmallCap 600 addition
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Catalyst Pharmaceuticals Shares Rise 8.6% on Pending Move to S&P SmallCap 600
Catalyst Pharmaceuticals Shares Rise 8.6% on Pending Move to S&P SmallCap 600...…
Zacks.com featured highlights include Tsakos Energy, AVEO Pharmaceuticals and Catalyst Pharmaceuticals
Tsakos Energy, AVEO Pharmaceuticals and Catalyst Pharmaceuticals have been highlighted in this Screen of The Week article....…
Why Catalyst Pharmaceuticals Stock Marched Higher This Week
This supercharged growth stock posted a new all-time high this week....…
Catalyst Pharmaceuticals to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
CORAL GABLES, Fla., Sept. 09, 2022 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical…
Catalyst Pharmaceutical (CPRX) Just Reclaimed the 20-Day Moving Average
Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?...…